Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in arthroscopic rotator cuff repair
ChiCTR2300074071Phase 4Not yet recruiting
- Sponsor
- Shifang People's Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Rotator cuff deficiency (RCD) comparing TXA group with Control (placebo) group (2 arms). Primary endpoints: d-dimer, fibrinogen degradation product (FDP) and 2 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2300074071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074071.